Literature DB >> 22525514

In vivo gene delivery by nonviral vectors: overcoming hurdles?

Yuan Zhang1, Andrew Satterlee, Leaf Huang.   

Abstract

The promise of cancer gene therapeutics is hampered by difficulties in the in vivo delivery to the targeted tumor cells, and systemic delivery remains to be the biggest challenge to be overcome. Here, we concentrate on systemic in vivo gene delivery for cancer therapy using nonviral vectors. In this review, we summarize the existing delivery barriers together with the requirements and strategies to overcome these problems. We will also introduce the current progress in the design of nonviral vectors, and briefly discuss their safety issues.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22525514      PMCID: PMC3392980          DOI: 10.1038/mt.2012.79

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  71 in total

Review 1.  Efficient and targeted delivery of siRNA in vivo.

Authors:  Min Suk Shim; Young Jik Kwon
Journal:  FEBS J       Date:  2010-12       Impact factor: 5.542

Review 2.  RNA interference therapy via functionalized scaffolds.

Authors:  Michael Monaghan; Abhay Pandit
Journal:  Adv Drug Deliv Rev       Date:  2011-01-15       Impact factor: 15.470

3.  Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo.

Authors:  Greg F Walker; Carolin Fella; Jaroslav Pelisek; Julia Fahrmeir; Sabine Boeckle; Manfred Ogris; Ernst Wagner
Journal:  Mol Ther       Date:  2005-03       Impact factor: 11.454

4.  Targeted nanoparticles deliver siRNA to melanoma.

Authors:  Yunching Chen; Surendar R Bathula; Qi Yang; Leaf Huang
Journal:  J Invest Dermatol       Date:  2010-08-05       Impact factor: 8.551

5.  Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.

Authors:  James O McNamara; Eran R Andrechek; Yong Wang; Kristi D Viles; Rachel E Rempel; Eli Gilboa; Bruce A Sullenger; Paloma H Giangrande
Journal:  Nat Biotechnol       Date:  2006-06-25       Impact factor: 54.908

6.  Enhanced laminin-derived peptide AG73-mediated liposomal gene transfer by bubble liposomes and ultrasound.

Authors:  Yoichi Negishi; Daiki Omata; Hiroshi Iijima; Yasuko Takabayashi; Kentaro Suzuki; Yoko Endo; Ryo Suzuki; Kazuo Maruyama; Motoyoshi Nomizu; Yukihiko Aramaki
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

7.  Elastase activated liposomal delivery to nucleated cells.

Authors:  C C Pak; R K Erukulla; P L Ahl; A S Janoff; P Meers
Journal:  Biochim Biophys Acta       Date:  1999-07-15

8.  Expression of therapeutic proteins after delivery of chemically modified mRNA in mice.

Authors:  Michael S D Kormann; Günther Hasenpusch; Manish K Aneja; Gabriela Nica; Andreas W Flemmer; Susanne Herber-Jonat; Marceline Huppmann; Lauren E Mays; Marta Illenyi; Andrea Schams; Matthias Griese; Iris Bittmann; Rupert Handgretinger; Dominik Hartl; Joseph Rosenecker; Carsten Rudolph
Journal:  Nat Biotechnol       Date:  2011-01-09       Impact factor: 54.908

Review 9.  Reversible covalent chemistry in drug delivery.

Authors:  Kevin R West; Sijbren Otto
Journal:  Curr Drug Discov Technol       Date:  2005-09

10.  A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.

Authors:  Hiroto Hatakeyama; Erika Ito; Hidetaka Akita; Motoi Oishi; Yukio Nagasaki; Shiroh Futaki; Hideyoshi Harashima
Journal:  J Control Release       Date:  2009-06-21       Impact factor: 9.776

View more
  92 in total

Review 1.  Overcoming Gene-Delivery Hurdles: Physiological Considerations for Nonviral Vectors.

Authors:  Andrew B Hill; Mingfu Chen; Chih-Kuang Chen; Blaine A Pfeifer; Charles H Jones
Journal:  Trends Biotechnol       Date:  2015-12-23       Impact factor: 19.536

Review 2.  Synthetic nucleic acids delivered by exosomes: a potential therapeutic for generelated metabolic brain diseases.

Authors:  Rutao Liu; Jing Liu; Xiaofei Ji; Yang Liu
Journal:  Metab Brain Dis       Date:  2013-12       Impact factor: 3.584

3.  Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi and Cancer Therapy.

Authors:  Xiaoding Xu; Phei Er Saw; Wei Tao; Yujing Li; Xiaoyuan Ji; Mikyung Yu; Morteza Mahmoudi; Jonathan Rasmussen; Dana Ayyash; Yuxiao Zhou; Omid C Farokhzad; Jinjun Shi
Journal:  Nano Lett       Date:  2017-06-26       Impact factor: 11.189

4.  Engineered nanoparticles for systemic siRNA delivery to malignant brain tumours.

Authors:  Johan Karlsson; Yuan Rui; Kristen L Kozielski; Amanda L Placone; Olivia Choi; Stephany Y Tzeng; Jayoung Kim; Jamal J Keyes; Max I Bogorad; Kathleen Gabrielson; Hugo Guerrero-Cazares; Alfredo Quiñones-Hinojosa; Peter C Searson; Jordan J Green
Journal:  Nanoscale       Date:  2019-10-15       Impact factor: 7.790

5.  The possible "proton sponge " effect of polyethylenimine (PEI) does not include change in lysosomal pH.

Authors:  Rikke V Benjaminsen; Maria A Mattebjerg; Jonas R Henriksen; S Moein Moghimi; Thomas L Andresen
Journal:  Mol Ther       Date:  2012-10-02       Impact factor: 11.454

6.  Systemic delivery of gemcitabine triphosphate via LCP nanoparticles for NSCLC and pancreatic cancer therapy.

Authors:  Yuan Zhang; William Y Kim; Leaf Huang
Journal:  Biomaterials       Date:  2013-02-04       Impact factor: 12.479

7.  Simulation and Experimental Assembly of DNA-Graft Copolymer Micelles with Controlled Morphology.

Authors:  Zonghui We; Yong Ren; John-Michael Williford; Wei Qu; Kevin Huang; Shirley Ng; Hai-Quan Mao; Erik Luijten
Journal:  ACS Biomater Sci Eng       Date:  2015-04-07

8.  Overcoming nonviral gene delivery barriers: perspective and future.

Authors:  Charles H Jones; Chih-Kuang Chen; Anitha Ravikrishnan; Snehal Rane; Blaine A Pfeifer
Journal:  Mol Pharm       Date:  2013-10-16       Impact factor: 4.939

9.  Non-invasive activation of optogenetic actuators.

Authors:  Elisabeth Birkner; Ken Berglund; Marguerita E Klein; George J Augustine; Ute Hochgeschwender
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2014-03-05

Review 10.  Anti-angiogenic gene therapy in the treatment of malignant gliomas.

Authors:  NaTosha N Gatson; E Antonio Chiocca; Balveen Kaur
Journal:  Neurosci Lett       Date:  2012-08-10       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.